Bio-Rad Laboratories (BIO) Operating Income (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Operating Income for 18 consecutive years, with $72.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Income fell 5.84% year-over-year to $72.6 million in Q2 2026; TTM through Jun 2026 was $53.1 million, a 76.25% decrease from a year earlier, with the FY2025 full-year figure at $47.2 million, down 82.45% from the prior year.
• Operating Income was $72.6 million for Q2 2026 at Bio-Rad Laboratories, up from $34.1 million in the prior quarter.
• Over five years, Operating Income peaked at $146.4 million in Q1 2022 and troughed at -$118.9 million in Q4 2025.
• A 5-year average of $69.1 million and a median of $74.8 million in 2025 frame the typical range for Operating Income.
• Across the five-year window, Operating Income surged 45.16% in 2022 and plunged 303.95% in 2025, its largest moves.
• Over 5 years, Operating Income stood at $118.7 million in 2022, then retreated by 19.66% to $95.3 million in 2023, then plunged by 38.84% to $58.3 million in 2024, then sank by 303.95% to -$118.9 million in 2025, then surged by 161.06% to $72.6 million in 2026.
• The last three Operating Income figures came in at $72.6 million (Q2 2026), $34.1 million (Q1 2026), and -$118.9 million (Q4 2025), per Business Quant data.